Skip to main content

Table 4 Daytime sleepiness and quality of life questionnaires according to obstructive sleep apnea severity

From: Association between obstructive sleep apnea severity and endothelial dysfunction in patients with type 2 diabetes

 

AHI < 15

15 ≤ AHI < 30

AHI > 30

p value

p value*

Daytime sleepiness

 ESS

7.5 (4.3)

8.5 (5.3)

10.6 (5.3)

0.01

0.08

 ESS ≥ 11, %

22.8

37.5

46.0

0.06

–

Quality of life

 SF36 PCS

50.4 (2.3)

50.6 (2.5)

51.0 (2.2)

0.51

–

 SF36 MCS

48.1 (5.9)

47.0 (6.5)

45.4 (6.4)

0.12

–

 SF36 bodily pain

60.4 (24.7)

60.9 (29.2)

54.1 (26.0)

0.41

–

 SF36 energy/vitality

57.1 (20.8)

52.1 (25.9)

43.0 (23.8)

0.02

0.02

 SF36 general health

65.6 (21.8)

62.3 (18.2)

56.2 (22.0)

0.11

–

 SF36 mental health

67.6 (20.3)

63.5 (23.1)

57.8 (22.0)

0.09

–

 SF36 physical functioning

72.3 (25.8)

65.4 (27.3)

62.5 (28.3)

0.24

 

 SF36 role emotional

82.1 (34.1)

76.0 (35.4)

65.1 (42.0)

0.10

–

 SF36 role physical

83.3 (30.5)

66.0 (40.1)

58.0 (40.7)

0.007

0.01

 SF36 social functioning

75.5 (28.7)

76.6 (25.7)

61.6 (31.1)

0.03

0.04

  1. Data are expressed as mean (standard deviation) or percentages
  2. ESS Epworth sleepiness scale, PSQI Pittsburgh sleep quality index, PCS physical component score, MCS mental component score
  3. * p values were adjusted for age, gender, body mass index, insulin and injectable GLP-1 analog use